Flora Peyvandi/X
Apr 12, 2026, 13:26
Flora Peyvandi: What Can Be Alternative to Warfarin
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared a post on X about a recent article by James H. Morrissey, published in ASH Publications:
“Warfarin may be more effective in high-thrombotic-risk conditions because it lowers prothrombin levels, a clotting protein with a long half-life (60–72 hours).
This long half-life helps smooth out fluctuations in drug effect over time.”
Title: A different alternative to warfarin?
Author: James H. Morrissey
Read the Full Article on ASH Publications
More posts featuring Flora Peyvandi on Hemostasis Today.
-
Apr 12, 2026, 13:21Can We Better Predict Who Is Most Likely to Have Another VTE After a First Event? – RPTH Journal
-
Apr 12, 2026, 13:18Gareth Owens: Advancing Aortic Disease Awareness Through Think Aorta
-
Apr 12, 2026, 13:11Denis Oduor: Apheresis Donation and Blood Component Therapy
-
Apr 12, 2026, 13:04Arsene Mekinian Featured in the Journal of Internal Medicine – Santé Arménie
-
Apr 12, 2026, 13:04Toward Nationwide Hemophilia Care in Armenia by 2030 – WFH
-
Apr 12, 2026, 12:56Chokri Ben Lamine: Clinical Dosing and Special Populations Guide for Apixaban
-
Apr 12, 2026, 12:04Riccardo Fumagalli: Long Term Complications Following Catheter Directed Thrombolysis in PE
-
Apr 12, 2026, 11:36Ifeanyichukwu Ifechidere: From Running Tests to Trusting Interpretation in Coagulation
-
Apr 12, 2026, 11:30Zack Rosanova: What Happens to Your Brain Without Sleep